Healthtech funding in February 2023
European Healthtech startup funding raised during February 2023.
In February 2023, 54 European Healthtech companies closed 54 funding rounds and raised €412M in equity funding (excluding debt and grants), down 47.5% versus February 2022. Debt rounds added €168M. Germany led by capital raised, and European Innovation Council (EIC) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€412M
-47.5% vs February 2022 · excl. debt & grants · +€168M debt
Funding rounds
54
-10.0% vs February 2022
Companies
54
Top country
Germany
Rank among sectors
#3
12.5% of sector funding
Debt financing
€168M
29.0% of total
Top-10 round share
76.7%
of disclosed capital
Rounds ≥ €100M
2
Top countries
by € raisedHealthtech — top countries by capital, February 2023 — interactive chart.
Data table
| Healthtech — top countries by capital, February 2023 | |
|---|---|
| Germany | €163M |
| Denmark | €127M |
| UK | €114M |
| Switzerland | €53M |
| Finland | €24M |
| France | €23M |
| Estonia | €18M |
| Sweden | €18M |
Stage mix
by € raisedHealthtech — stage mix, February 2023 — interactive chart.
Data table
| Healthtech — stage mix, February 2023 | |
|---|---|
| Debt | €168M |
| Series B | €157M |
| Other | €154M |
| Series A | €47M |
| Series D+ | €32M |
| Seed | €20M |
| Pre-Seed | €1.8M |
| Growth/Late | €1.0M |
Top deals
largest disclosed rounds in February 2023| Company | Stage | Date | Amount |
|---|---|---|---|
| Evotec | Debt | Feb 2023 | €150M |
| Hemab Therapeutics | Series B | Feb 2023 | €127M |
| Xeltis | Series D+ | Feb 2023 | €32M |
| Prokarium | Other | Feb 2023 | €28M |
| Evonetix | Series B | Feb 2023 | €22M |
| Tilt Biotherapeutics | Other | Feb 2023 | €22M |
| Icosagen | Debt | Feb 2023 | €18M |
| Syntach | Other | Feb 2023 | €18M |
| Maxion Therapeutics | Series A | Feb 2023 | €15M |
| Oculis | Other | Feb 2023 | €14M |
| DrDoctor | Other | Feb 2023 | €11M |
| Phlo | Series A | Feb 2023 | €11M |
| Dxcover | Series A | Feb 2023 | €11M |
| Resalis Therapeutics | Seed | Feb 2023 | €10M |
| Avicenna.ai | Series A | Feb 2023 | €10M |
Top investors
most active in February 2023, by deal count- European Innovation Council (EIC)2 deals
- European Investment Bank (EIB)2 deals
- IBB Ventures2 deals
- Scottish Enterprise2 deals
- Venture Kick2 deals
- WiSEED2 deals
- 4Founders Capital1 deals
- 50 Partners1 deals
- 8a+ Investment SGR1 deals
- Access Biotechnology1 deals